NCT00011076View on ClinicalTrials.gov

Pirfenidone to Treat Hypertrophic Cardiomyopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2001

Study Completion Date

April 30, 2003

Conditions
Hypertrophic Cardiomyopathy
Interventions
DRUG

Pirfenidone

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00011076 - Pirfenidone to Treat Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter